Semaglutide
Weight management, cardiometabolic risk reduction, and broader metabolic conversations such as MASH.
Evidence
Authorized prescription medicine in the U.S. and EU with large human outcome data in obesity and cardiometabolic care.
Reality check
Use through licensed prescribing and regulated supply only. Counterfeit and non-FDA-approved copies are a real market problem.
Plan note: Discussion plan: confirm indication, contraindications, and whether the product source is a licensed pharmacy or health-system channel.
Tap for details